微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.4% | -12.73% | -70.22% | 32/140 | 1.2% | 健帆生物 | 9.87% | 行业排名> |
| 2025-12-31 | 8.06% | -30.46% | 21.2% | 30/140 | 2.37% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-09-30 | 6.65% | -29.03% | 52.87% | 35/140 | 4.19% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-06-30 | 4.35% | -26.15% | 58.18% | 36/140 | 2.43% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-03-31 | 2.75% | -4.84% | -76.27% | 26/140 | 1.42% | 惠泰医疗 | 15.03% | 行业排名> |
| 2024-12-31 | 11.59% | 13.07% | 23.69% | 17/140 | 4.14% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-09-30 | 9.37% | 9.46% | 59.08% | 20/140 | 5.03% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-06-30 | 5.89% | 14.59% | 103.81% | 26/140 | 3.15% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-03-31 | 2.89% | 22.46% | -71.8% | 29/140 | 1.75% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2023-12-31 | 10.25% | -14.37% | 19.74% | 30/140 | 5.44% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-09-30 | 8.56% | -23.43% | 66.54% | 39/140 | 6.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-06-30 | 5.14% | -28.51% | 117.8% | 44/140 | 3.96% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-03-31 | 2.36% | -33.33% | -80.28% | 53/140 | 2.33% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2022-12-31 | 11.97% | -6.92% | 7.07% | 59/140 | 13.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-09-30 | 11.18% | 5.08% | 55.49% | 50/140 | 13.94% | 九安医疗 | 146.56% | 行业排名> |
| 2022-06-30 | 7.19% | 9.1% | 103.11% | 53/140 | 9.74% | 九安医疗 | 140.94% | 行业排名> |
| 2022-03-31 | 3.54% | -1.67% | -72.47% | 43/140 | 6.8% | 九安医疗 | 142.25% | 行业排名> |
| 2021-12-31 | 12.86% | -5.93% | 20.86% | 68/140 | 18.45% | 九安医疗 | 142.71% | 行业排名> |
| 2021-09-30 | 10.64% | 2.6% | 61.46% | 56/140 | 16.59% | 热景生物 | 121.78% | 行业排名> |
| 2021-06-30 | 6.59% | 1.38% | 83.06% | 60/140 | 11.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-03-31 | 3.6% | 4.35% | -73.66% | 45/140 | 6.49% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 13.67% | 11.77% | 31.82% | 74/140 | 26.27% | 热景生物 | 57.63% | 行业排名> |
| 2020-09-30 | 10.37% | 11.15% | 59.54% | 52/140 | 19.98% | 中红医疗 | 168% | 行业排名> |
| 2020-06-30 | 6.5% | 7.62% | 88.41% | 64/140 | 15.17% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-03-31 | 3.45% | 11.29% | -71.79% | 24/140 | 3.31% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 12.23% | 20.61% | 31.08% | 67/140 | 14.66% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-09-30 | 9.33% | 18.85% | 54.47% | 32/140 | 10.54% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 6.04% | 18.66% | 94.84% | 35/140 | 6.76% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-03-31 | 3.1% | 23.02% | -69.43% | 18/140 | 2.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-12-31 | 10.14% | 30% | 29.17% | 71/140 | 14.23% | 新华医疗 | 13.55% | 行业排名> |
| 2018-09-30 | 7.85% | 22.66% | 54.22% | 32/140 | 9.71% | 安旭生物 | 48.71% | 行业排名> |
| 2018-06-30 | 5.09% | 20.33% | 101.98% | 26/140 | 4.54% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-03-31 | 2.52% | 19.43% | -67.69% | 23/140 | 2.78% | *ST明德 | 14.54% | 行业排名> |
| 2017-12-31 | 7.8% | -11.16% | 21.88% | 72/140 | 14.51% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-09-30 | 6.4% | 12.08% | 51.3% | 31/140 | 9.49% | 安旭生物 | 59.22% | 行业排名> |
| 2017-06-30 | 4.23% | 0% | 100.47% | 38/140 | 6.11% | 大博医疗 | 30.55% | 行业排名> |
| 2017-03-31 | 2.11% | 22.67% | -75.97% | 22/140 | 2.74% | 基蛋生物 | 23.11% | 行业排名> |
| 2016-12-31 | 8.78% | 29.5% | 53.77% | 55/140 | 16.44% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-09-30 | 5.71% | 8.56% | 34.99% | 28/140 | 8.86% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-06-30 | 4.23% | 25.89% | 145.93% | 30/140 | 6.35% | 安图生物 | 28% | 行业排名> |
| 2016-03-31 | 1.72% | 13.16% | -74.63% | 22/140 | 2.3% | *ST明德 | 23.29% | 行业排名> |